Table 1.
Summary of subgroups' characteristics in studies assessing the effects of pre/probiotics for the treatment of bacterial vaginosis
| Subgroups | Patients (N) | Trials (N) |
|---|---|---|
| BV diagnostic standards | ||
| Amsel's criteria | 3,842 | 14 |
| Nugent's criteria | 4,400 | 10 |
| Route of intervention | ||
| Oral | 3,711 | 12 |
| Vaginal | 4,531 | 12 |
| Regimens combined with pre/probiotics | ||
| Clindamycin | 450 | 1 |
| Metronidazole | 1,256 | 10 |
| Pregnancy status | ||
| Pregnant | 5,182 | 7 |
| Nonpregnant | 3,060 | 17 |
| Follow-up duration | ||
| Short term (≤ 1 month) | 2,940 | 11 |
| Long term (>1 month) | 5,484 | 13 |
Total number of patients in all the 24 included trials: 8,242.